Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat

Previous work has established the existence of dystrophin–nitric oxide (NO) signaling to histone deacetylases (HDACs) that is deregulated in dystrophic muscles. As such, pharmacological interventions that target HDACs (that is, HDAC inhibitors) are of potential therapeutic interest for the treatment...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Consalvi, Silvia, Mozzetta, Chiara, Bettica, Paolo, Germani, Massimiliano, Fiorentini, Francesco, Del Bene, Francesca, Rocchetti, Maurizio, Leoni, Flavio, Monzani, Valmen, Mascagni, Paolo, Puri, Pier Lorenzo, Saccone, Valentina
Format: Artigo
Jezik:Inglês
Izdano: ScholarOne 2013
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667212/
https://ncbi.nlm.nih.gov/pubmed/23552722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2013.00011
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki